ClinicalTrials.Veeva

Menu

Clinical and Economical Assessment of an Intervention to Reduce Potentially Inappropriate Medication in Polymedicated Elderly Patients (REMEI)

C

Consorci Sanitari del Maresme

Status

Completed

Conditions

Polypharmacy
Elderly

Treatments

Procedure: Pharmacist Intervention

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Objective: To evaluate the clinical and economic impact of the application of an algorithm to improve the adequacy and safety of pharmacotherapy in elderly polymedicated (receiving 8 or more medications), not institutionalized.

Design: randomized, open, multicenter and two branches of parallel intervention clinical trial.

Intervention Study: primary care pharmacist apply the GP-GP algorithm to each drug with the support of STOPP criteria, Beers and / or recommendations CatSalut. The pharmacist submit to doctor his findings and reach a consensus and decide which recommendations will be presented to patient. Control intervention: usual procedure.

Main outcome measures: a) Discontinued medications, changed or changing doses, b) GP consultations, hospital emergency department and hospital admissions for acute illness, c) pharmaceutical expenditure, d) restart medication e) complications underlying diseases. Follow-up control at 1 month (security) and at 3, 6 and 12 months.

Enrollment

503 patients

Sex

All

Ages

70+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 70 years or more
  • Currently receiving eight or more drugs, except ointments and administered via topical nonprescription
  • Give their informed written consent to participate in the study.

Exclusion criteria

  • Estimated life expectancy less than 6 months.
  • Active cancer
  • Participation in any other clinical trial or program for evaluation of medication in the elderly.
  • Institutionalized in nursing homes.
  • Surgical intervention scheduled for the next 6 months

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

503 participants in 2 patient groups

Pharmacist Intervention
Experimental group
Description:
Primary care pharmacist apply the GP-GP algorithm to each drug with the support of STOPP criteria, Beers and / or recommendations CatSalut. The pharmacist submit to doctor his findings and reach a consensus and decide which recommendations will be presented to patient.
Treatment:
Procedure: Pharmacist Intervention
Control
No Intervention group
Description:
Usual procedure.

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems